Shell Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96K | Sell |
4,173
-460
| -10% | -$10.6K | ﹤0.01% | 1019 |
|
|
2025
Q1 | $134K | Sell |
4,633
-201
| -4% | -$5.81K | 0.01% | 932 |
|
|
2024
Q4 | $179K | Sell |
4,834
-16
| -0.3% | -$592 | 0.01% | 876 |
|
|
2024
Q3 | $235K | Buy |
+4,850
| New | +$235K | 0.01% | 771 |
|
|
2024
Q1 | $205K | Sell |
5,128
-514
| -9% | -$20.5K | 0.01% | 809 |
|
|
2023
Q4 | $349K | Sell |
5,642
-1,697
| -23% | -$105K | 0.02% | 650 |
|
|
2023
Q3 | $338K | Sell |
7,339
-3,696
| -33% | -$170K | 0.01% | 716 |
|
|
2023
Q2 | $634K | Sell |
11,035
-63
| -0.6% | -$3.62K | 0.03% | 498 |
|
|
2023
Q1 | $416K | Sell |
11,098
-39
| -0.4% | -$1.46K | 0.02% | 640 |
|
|
2022
Q4 | $312K | Sell |
11,137
-2,261
| -17% | -$63.3K | 0.01% | 756 |
|
|
2022
Q3 | $376K | Sell |
13,398
-3,510
| -21% | -$98.5K | 0.01% | 717 |
|
|
2022
Q2 | $588K | Sell |
16,908
-15,495
| -48% | -$539K | 0.02% | 627 |
|
|
2022
Q1 | $1.16M | Sell |
32,403
-4,796
| -13% | -$172K | 0.03% | 451 |
|
|
2021
Q4 | $866K | Buy |
37,199
+177
| +0.5% | +$4.12K | 0.02% | 626 |
|
|
2021
Q3 | $704K | Sell |
37,022
-1,600
| -4% | -$30.4K | 0.02% | 687 |
|
|
2021
Q2 | $779K | Buy |
38,622
+2,090
| +6% | +$42.2K | 0.02% | 689 |
|
|
2021
Q1 | $669K | Buy |
36,532
+18,908
| +107% | +$346K | 0.01% | 724 |
|
|
2020
Q4 | $354K | Hold |
17,624
| – | – | 0.01% | 941 |
|
|
2020
Q3 | $330K | Buy |
17,624
+3,437
| +24% | +$64.4K | 0.01% | 865 |
|
|
2020
Q2 | $319K | Buy |
+14,187
| New | +$319K | 0.01% | 864 |
|